Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device

References

1. 1.↵
   2. Arrese I,
   3. Sarabia R,
   4. Pintado R, et al

   . Flow-diverter devices for intracranial aneurysms: systematic review and meta-analysis. Neurosurgery 2013;73:193–99 ; discussion 199–200 doi:10.1227/01.neu.0000430297.17961.f1 pmid:23624409

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Briganti F,
   3. Napoli M,
   4. Tortora F, et al

   . Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications—a retrospective data analysis. Neuroradiology 2012;54:1145–52 doi:10.1007/s00234-012-1047-3 pmid:22569955

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Brinjikji W,
   3. Murad MH,
   4. Lanzino G, et al

   . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–47 doi:10.1161/STROKEAHA.112.678151 pmid:23321438

   Abstract/FREE Full Text
4. 4.↵
   2. Yu SC,
   3. Kwok CK,
   4. Cheng PW, et al

   . Intracranial aneurysms: midterm outcome of Pipeline embolization device—a prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893–901 doi:10.1148/radiol.12120422 pmid:22996749

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Kallmes DF,
   3. Ding YH,
   4. Dai D, et al

   . A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke 2007;38:2346–52 doi:10.1161/STROKEAHA.106.479576 pmid:17615366

   Abstract/FREE Full Text
6. 6.↵
   2. Kallmes DF,
   3. Ding YH,
   4. Dai D, et al

   . A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol 2009;30:1153–58 doi:10.3174/ajnr.A1530 pmid:19369609

   Abstract/FREE Full Text
7. 7.↵
   2. Karaźniewicz-Lada M,
   3. Danielak D,
   4. Burchardt P, et al

   . Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Clin Pharmacokinet 2014;53:155–64 doi:10.1007/s40262-013-0105-2 pmid:24127209

   CrossRefPubMed
8. 8.↵
   2. Delgado Almandoz JE,
   3. Crandall BM,
   4. Scholz JM, et al

   . Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline embolization device. J Neurointerv Surg 2013;5(suppl 3):iii3-10 doi:10.1136/neurintsurg-2012-010582 pmid:23314576

   Abstract/FREE Full Text
9. 9.↵
   2. Fifi JT,
   3. Brockington C,
   4. Narang J, et al

   . Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. AJNR Am J Neuroradiol 2013;34:716–20 doi:10.3174/ajnr.A3405 pmid:23194833

   Abstract/FREE Full Text
10. 10.↵
    2. Comin J,
    3. Kallmes DF

    . Platelet-function testing in patients undergoing neurovascular procedures: caught between a rock and a hard place. AJNR Am J Neuroradiol 2013;34:730–34 doi:10.3174/ajnr.A3440 pmid:23257609

    Abstract/FREE Full Text
11. 11.↵
    2. Kallmes DF,
    3. Hanel R,
    4. Lopes D, et al

    . International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

    Abstract/FREE Full Text
12. 12.↵
    2. Tan LA,
    3. Keigher KM,
    4. Munich SA, et al

    . Thromboembolic complications with Pipeline embolization device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value. J Neurointerv Surg 2015;7:217–21 doi:10.1136/neurintsurg-2014-011111 pmid:24553344

    Abstract/FREE Full Text
13. 13.↵
    2. Delgado Almandoz JE,
    3. Kadkhodayan Y,
    4. Crandall BM, et al

    . Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 2014;6:767–73 doi:10.1136/neurintsurg-2013-010976 pmid:24353331

    Abstract/FREE Full Text
14. 14.↵
    2. Goh C,
    3. Churilov L,
    4. Mitchell P, et al

    . Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 2013;34:721–26 doi:10.3174/ajnr.A3418 pmid:23275598

    Abstract/FREE Full Text
15. 15.↵
    2. Heller RS,
    3. Dandamudi V,
    4. Lanfranchi M, et al

    . Effect of antiplatelet therapy on thromboembolism after flow diversion with the Pipeline embolization device. J Neurosurg 2013;119:1603–10 doi:10.3171/2013.7.JNS122178 pmid:23971953

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Oran I,
    3. Cinar C,
    4. Bozkaya H, et al

    . Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation. J Neurointerv Surg 2015;7:357–62 doi:10.1136/neurintsurg-2013-011023 pmid:24721755

    Abstract/FREE Full Text
17. 17.↵
    2. Nordeen JD,
    3. Patel AV,
    4. Darracott RM, et al

    . Clopidogrel resistance by P2Y12 platelet function testing in patients undergoing neuroendovascular procedures: incidence of ischemic and hemorrhagic complications. J Vasc Interv Neurol 2013;6:26–34 pmid:23826440

    PubMed
18. 18.↵
    2. Price MJ,
    3. Berger PB,
    4. Teirstein PS, et al

    ; GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 2011;305:1097–105 doi:10.1001/jama.2011.290 pmid:21406646

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Aradi D,
    3. Komócsi A,
    4. Price MJ, et al

    ; Tailored Antiplatelet Treatment Study Collaboration. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol 2013;167:2140–48 doi:10.1016/j.ijcard.2012.05.100 pmid:22704866

    CrossRefPubMed
20. 20.↵
    2. Aradi D,
    3. Storey RF,
    4. Komócsi A, et al

    ; Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J 2014;35:209–15 doi:10.1093/eurheartj/eht375 pmid:24067509

    FREE Full Text